FDA Approved: INVEGA HAFYERA — Supplemental Application (Janssen Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved a supplemental application for Invega Hafyera (paliperidone palmitate) from Janssen Pharmaceuticals, Inc., updating the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• INVEGA HAFYERA (PALIPERIDONE PALMITATE)

Snippet

SUPPL AP for INVEGA HAFYERA (PALIPERIDONE PALMITATE)